CereScan is Coming to Denver Area Theaters

Share Article

CereScan Corp., the national leader in providing statistically measured brain diagnostics, will reach Denver area theater audiences in December and January through advertising in select theaters.

CereScan Corp. is bringing its message of hope to those suffering from the chronic effects of concussions and Traumatic Brain Injury (TBI) through theater advertisements in December and January. Through the website http://www.AreYouSuffering.com, audiences in select Denver area theaters are invited to seek help for the debilitating effects of head trauma by contacting a CereScan brain injury expert.

“Over four million U.S. athletes suffer from the effects of concussions each year,” said John Kelley, Chairman and CEO of CereScan Corp. “CereScan is a valuable local resource and a recognized leader in the diagnosis of TBI and other brain disorders.”

The theater advertising campaign focuses on brain injury awareness and providing hope. It also highlights CereScan’s innovative imaging technology and mission of finding solutions for those suffering from brain injuries and disorders.

Unlike MRI and CT scans, which take structural images of the brain, CereScan’s technology can make invisible injuries visible through the use of functional brain imaging and advanced software. When the brain is scanned, blood flow levels are mapped within the brain to pinpoint where blood flow is normal and where it isn’t. Based on the signature patterns of brain based disorders, a diagnosis can be more accurately identified.

CereScan, based in Littleton, Colorado, with affiliate clinics in Dallas and Houston, Texas, New Orleans, Louisiana, Naples, Florida, and Topeka, Kansas, is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:

  •     Traumatic Brain Injury
  •     Toxic Brain Injury
  •     Alzheimer’s Disease
  •     Mild Cognitive Impairment
  •     Other Dementias
  •     Parkinson’s Disease
  •     Obsessive Compulsive Disorder
  •     Bipolar Disorder
  •     ADD/ADHD
  •     Anxiety Disorder

About CereScan

CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Kelley

Gail McClurg
Follow >
Visit website